Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ben‑Fu He"'
Autor:
LI-MIN LONG1, BEN-FU HE2, GUO-QING HUANG3, YONG-HONG GUO1, YOU-SHUO LIU1, JI-RONG HUO4 huojirong0011@163.com
Publikováno v:
Oncology Letters. 2015, Vol. 9 Issue 2, p645-650. 6p.
Publikováno v:
Oncology Letters
microRNAs (miRNAs/miRs) are a conserved class of endogenous, short non-coding RNAs that post-transcriptionally regulate the expression of genes involved in diverse cellular processes. miR-214 has been reported to be associated with several cancers, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113cd7747b67c4ef3f2002a43e35acbf
https://doi.org/10.3892/ol.2014.2746
https://doi.org/10.3892/ol.2014.2746
Publikováno v:
Breast Cancer Research and Treatment. 122:259-265
Epidemiological studies have evaluated the association between CYP17 MspA1 polymorphism and breast cancer risk. However, the results remain conflicting rather than conclusive. To derive a more precise estimation of the relationship, we performed this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23c034f2a01e7a05fa36f1de03ac4d6
https://doi.org/10.1007/s10549-009-0695-4
https://doi.org/10.1007/s10549-009-0695-4
Autor:
Jingran Xie, Li Zhang, Lixia Wei, Guanzhu Shen, Huiyan Luo, Wei Gong, Ben-fu He, Luo-sheng Zhang, Yuxin Duan, Na Min, Xingwang Gao
Publikováno v:
Molecular medicine reports. 11(1)
Cathepsin L (CTSL) is a lysosomal cysteine protease that has been found to be overexpressed in ovarian cancer (OC). The aim of the present study was to investigate the possible involvement of CTSL in the development of OC. In this study, RNA interfer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a014a7934e239db8e509181785cb3cab
https://pubmed.ncbi.nlm.nih.gov/25333746
https://pubmed.ncbi.nlm.nih.gov/25333746
Autor:
Zuyao Yang, Jin-Ling Tang, Qing Chen, Shan Liu, Ben-Fu He, Chen Mao, Rong-Cheng Luo, Junhua Zhou
Publikováno v:
The Cochrane Library
Cochrane Database Syst Rev
Cochrane Database Syst Rev
Background Toremifene (TOR) and tamoxifen (TAM) can both be used as treatments for advanced breast cancer. Objectives To compare the efficacy and safety of TOR with TAM in patients with advanced breast cancer. Search methods The Cochrane Breast Cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc6814cfd116ebbe2513682caf8a5e07
https://doi.org/10.1002/14651858.cd008926.pub2
https://doi.org/10.1002/14651858.cd008926.pub2
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 31(6)
To study the radiosensitizing effect of gefitinib on nasopharyngeal carcinoma cell line CNE2 in vitro.Nasopharyngeal carcinoma cell line CNE2 was cultured in RP2MI 1640. MTT assay was performed to evaluate the cell proliferation changes in response t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2c5e4eec6a1160aa3eb0c4042d13cad0
https://pubmed.ncbi.nlm.nih.gov/21690052
https://pubmed.ncbi.nlm.nih.gov/21690052
Publikováno v:
Molecular biology reports. 39(2)
Epidemiological studies have evaluated the association between ATM 5557G>A (p.D1853N) polymorphism and breast cancer risk. However, the results remain conflicting rather than conclusive. To derive a more precise estimation of the relationship, we per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3327ff069c4fe6a97000e5523e38b2e4
https://pubmed.ncbi.nlm.nih.gov/21603857
https://pubmed.ncbi.nlm.nih.gov/21603857
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 30(4)
To evaluate the inhibitory effect of recombinant adenovirus carrying human endostatin gene (Ad-endo) on the growth of human pancreatic carcinoma xenograft in nude mice.The expression of endostatin in human pancreatic carcinoma Capan-2 cells was exami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0646e49d7e57c6a62b1dd377b77129e8
https://pubmed.ncbi.nlm.nih.gov/20423871
https://pubmed.ncbi.nlm.nih.gov/20423871
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 30(3)
To evaluate the efficacy and toxicity of the combined therapy with oxaliplatin and capecitabine (XELOX) in patients with advanced or recurrent gastric cancer.Forty-one patients with previously untreated advanced or recurrent gastric cancer received i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::392b0892be47b827a36218a4bad6b073
https://pubmed.ncbi.nlm.nih.gov/20335149
https://pubmed.ncbi.nlm.nih.gov/20335149